We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$4.7B
AUM Growth
-$238M
Cap. Flow
-$118M
Cap. Flow %
-2.51%
Top 10 Hldgs %
27.49%
Holding
1,425
New
528
Increased
233
Reduced
492
Closed
45

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$33.5M
2
AMT icon
American Tower
AMT
+$31.3M
3
EQIX icon
Equinix
EQIX
+$12.7M
4
SBAC icon
SBA Communications
SBAC
+$8.56M
5
LAMR icon
Lamar Advertising Co
LAMR
+$6.7M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.1M
2
MSFT icon
Microsoft
MSFT
+$34M
3
AMZN icon
Amazon
AMZN
+$23.1M
4
OUT icon
Outfront Media
OUT
+$17.7M
5
UNIT
Uniti Group
UNIT
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 21.72%
2 Real Estate 17.45%
3 Consumer Discretionary 10.45%
4 Healthcare 9.89%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
1101
Alnylam Pharmaceuticals
ALNY
$38.5B
$122K ﹤0.01%
+838
New +$119K
HALO icon
1102
Halozyme
HALO
$9.9B
$121K ﹤0.01%
+4,606
New +$128K
NWS icon
1103
News Corp Class B
NWS
$17.2B
$120K ﹤0.01%
8,579
-1,716
-17% -$23.9K
IOVA icon
1104
Iovance Biotherapeutics
IOVA
$2.1B
$117K ﹤0.01%
+3,561
New +$109K
HSII
1105
DELISTED
Heidrick & Struggles
HSII
$115K ﹤0.01%
5,856
+929
+19% +$19.5K
ACLS icon
1106
Axcelis
ACLS
$3.69B
$114K ﹤0.01%
+5,175
New +$132K
ALLK
1107
DELISTED
Allakos
ALLK
$114K ﹤0.01%
+1,399
New +$114K
DBX icon
1108
Dropbox
DBX
$7.48B
$114K ﹤0.01%
+5,922
New +$123K
KYNB
1109
Kyntra Bio
KYNB
$28.2M
$113K ﹤0.01%
+110
New +$118K
HVT icon
1110
Haverty Furniture Companies
HVT
$421M
$106K ﹤0.01%
+5,050
New +$91.5K
LDL
1111
DELISTED
Lydall, Inc.
LDL
$106K ﹤0.01%
6,396
-851
-12% -$14.8K
VNDA icon
1112
Vanda Pharmaceuticals
VNDA
$310M
$104K ﹤0.01%
10,817
+5,641
+109% +$60.3K
EDIT icon
1113
Editas Medicine
EDIT
$402M
$103K ﹤0.01%
+3,684
New +$120K
APLS
1114
DELISTED
Apellis Pharmaceuticals
APLS
$102K ﹤0.01%
+3,391
New +$101K
EQC
1115
DELISTED
Equity Commonwealth
EQC
$102K ﹤0.01%
3,824
-815
-18% -$25.2K
PTCT icon
1116
PTC Therapeutics
PTCT
$6.25B
$100K ﹤0.01%
+2,133
New +$105K
TEVA icon
1117
Teva Pharmaceuticals
TEVA
$36.9B
$100K ﹤0.01%
+11,055
New +$117K
MDGL icon
1118
Madrigal Pharmaceuticals
MDGL
$12.4B
$99K ﹤0.01%
+836
New +$90.8K
DCPH
1119
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$99K ﹤0.01%
+1,938
New +$94.9K
CLDR
1120
DELISTED
Cloudera, Inc.
CLDR
$98K ﹤0.01%
+8,994
New +$104K
TPTX
1121
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$97K ﹤0.01%
+1,111
New +$77.4K
ALLO icon
1122
Allogene Therapeutics
ALLO
$573M
$95K ﹤0.01%
+2,512
New +$94.7K
CDNA icon
1123
CareDx
CDNA
$1.85B
$95K ﹤0.01%
+2,494
New +$84.2K
ACAD icon
1124
Acadia Pharmaceuticals
ACAD
$4.45B
$94K ﹤0.01%
+2,290
New +$98.9K
INO icon
1125
Inovio Pharmaceuticals
INO
$84.7M
$94K ﹤0.01%
+673
New +$140K

Similar funds

Pacer Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Pacer Advisors held 1,425 positions worth $4.7B, down 4.8% from $4.94B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pacer Advisors's Q3 2020 filing shows 528 new, 233 increased, 492 reduced and 45 closed positions. Its largest new stake was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M. The largest sale was Apple, an estimated $41.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Real Estate and Consumer Discretionary.

  • Pacer Advisors's largest Q3 2020 buy was iShares MSCI South Korea ETF: 103,528 shares worth $6.76M.
  • Pacer Advisors added most to Crown Castle in Q3 2020, an estimated $33.5M increase.
  • Pacer Advisors's biggest Q3 2020 reduction was Apple, cutting an estimated $41.1M.
  • Pacer Advisors fully exited Dell in Q3 2020, selling an estimated $4.74M.
  • Pacer Advisors's ten largest holdings make up 27% of its $4.7B portfolio in Q3 2020.
  • Pacer Advisors opened 528 new positions and closed 45 in Q3 2020.
  • Pacer Advisors's portfolio value fell 4.8% quarter-over-quarter to $4.7B.

Based on Pacer Advisors's 13F filing for Q3 2020, filed 19 Oct 2020.